And who would decide? For these reasons, over 40 countries have banned human germline modification. Human germline editing is not just a scientific or technical issue. It affects how we understand ourselves as humans and what kind of future we want to build. It has implications for society as a whole , not just individuals. Therefore, decisions about whether to permit germline modification should not be made by small groups of scientists or bioethicists, by biotechnology companies, or by wealthy elites.
Human germline editing is an urgent social justice issue; we need public discussions of it that are open to all. These labs were deciphering the secrets of embryos and had a particular interest in how eggs are formed. Surgeons in New York have successfully attached a kidney grown in a genetically altered pig to a human patient and found that the organ worked normally, a scientific breakthrough that one day may yield a vast new supply of organs Many describe the move from bench to bedside from basic science to therapeutic or preventive applications as a sprint — a short quick race.
Others suggest that the race such as it is is more like hurdles given the many Main navigation. Search Search Donate Subscribe. What is Human Gene Editing? Gene Therapy: Changing genomes to treat disease There are two distinct ways gene editing might be used in humans. Germline Editing: Changing the genomes of future generations But there is a much more controversial way that human gene editing could be used.
Understanding the Social and Ethical Risks New technologies often raise ethical questions about their unknown risks and benefits. Who Gets to Decide? Related Articles. How Silicon Valley hatched a plan to turn blood into human eggs.
Aggregated News. Animal Biotechnologies. Mythmakers in the Market for Perfection. Now known only as Nana and Lulu — their identities protected in scientific version of the witness protection program — Dr. He and his collaborators were recently sentenced by a court in Shenzhen to three years in prison for conducting "illegal medical practices. The technology has a massive range of applications, and those applications carry different degrees of risk, depending on the kinds of cells edited.
Maybe you remember the distinction of somatic versus non-somatic cells from biology? Most of your cells are somatic: your eyes, your lungs, your heart.
For non-somatic, think sperm, eggs, embryos, stem cells: the cells directly used to create offspring. The difference is relevant because genetic modifications to reproductive non-somatic cells get passed on to the descendants of those organisms. The results of Dr. There was news last fall of a new gene-editing technology called " Prime-Editing.
There are many ways to edit genes, but the breakthrough behind the greatest achievements in recent years is a molecular tool called Crispr-Cas9. When the cell tries to fix the damage, it often makes a hash of it, and effectively disables the gene. This in itself is useful for turning off harmful genes.
But other kinds of repairs are possible. For example, to mend a faulty gene, scientists can cut the mutated DNA and replace it with a healthy strand that is injected alongside the Crispr-Cas9 molecules. Different enzymes can be used instead of Cas9, such as Cpf1, which may help edit DNA more effectively.
Remind me what genes are again? Genes are the biological templates the body uses to make the structural proteins and enzymes needed to build and maintain tissues and organs. They are made up of strands of genetic code, denoted by the letters G, C, T and A. Humans have about 20, genes bundled into 23 pairs of chromosomes all coiled up in the nucleus of nearly every cell in the body. Only about 1. The rest of our DNA is apparently useless.
What are all those Gs, Cs, Ts and As? The letters of the genetic code refer to the molecules guanine G , cytosine C , thymine T and adenine A.
It takes a lot of them to make a gene. The gene damaged in cystic fibrosis contains about , base pairs, while the one that is mutated in muscular dystrophy has about 2. Each of us inherits about 60 new mutations from our parents, the majority coming from our father. But how do you get to the right cells? This is the big challenge.
Most drugs are small molecules that can be ferried around the body in the bloodstream and delivered to organs and tissues on the way. The gene editing molecules are huge by comparison and have trouble getting into cells. But it can be done. One way is to pack the gene editing molecules into harmless viruses that infect particular types of cell.
Millions of these are then injected into the bloodstream or directly into affected tissues. Once in the body, the viruses invade the target cells and release the gene editing molecules to do their work. In , scientists in Texas used this approach to treat Duchenne muscular dystrophy in mice.
The next step is a clinical trial in humans. Viruses are not the only way to do this, though.
0コメント